PAVmed Inc.
PAVM· Nasdaq
Released Aug 12, 2024, after the close
10-Q filed Aug 12, 2024, 43 days after period end · 0001493152-24-031268
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $979.00K | $166.00K | $0.00 | — |
| Net Income | -$10.83M | -$14.54M | -$25.53M | -$11.47M |
| EPS Diluted | -$1.19 |
PAVmed Inc. · CIK 1624326 · Engraved from SEC EDGAR
| -$2.10 |
| -$0.29 |
| -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.